Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview
Open Access
- 28 February 2024
- Vol. 42 (8) , 2026-2035
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline (Zoster-042, Zoster-091)
This publication has 36 references indexed in Scilit:
- The adjuvanted recombinant zoster vaccine co-administered with the 13-valent pneumococcal conjugate vaccine in adults aged ≥50 years: A randomized trialJournal of Infection, 2022
- The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trialVaccine, 2019
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysisThe Lancet Infectious Diseases, 2019
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell TransplantationJAMA, 2019
- A report on the status of vaccination in EuropeVaccine, 2018
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trialVaccine, 2018
- MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trialVaccine, 2018
- Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter studyVaccine, 2018
- Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatmentThe Lancet Neurology, 2009
- Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancyVaccine, 1991